Sepiapterin Suppliers & Bulk Manufacturers
Available Forms: Tablets / oral powder
Available Strengths: 1000 mg, 250 mg
Reference Brands: Sephience (USA/EU)
Category:
Orphan Drugs
Sepiapterin is available in Tablets / oral powder
and strengths such as 1000 mg, 250 mg.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Sepiapterin is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Sepiapterin can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Sepiapterin is a phenylalanine hydroxylase activator used for the treatment of hyperphenylalaninemia, including phenylketonuria (PKU). Marketed under the brand name Sephience, Sepiapterin supports metabolic control in patients who are unable to adequately process phenylalanine due to enzymatic deficiency. It works by enhancing the activity of phenylalanine hydroxylase, a key enzyme responsible for converting phenylalanine into tyrosine, thereby helping to reduce elevated blood phenylalanine levels.
Sepiapterin is a naturally occurring metabolite synthesized in the human body and serves as a biochemical precursor in the salvage pathway leading to the formation of tetrahydrobiopterin (BH4). BH4 is an essential cofactor required for the normal metabolism of phenylalanine and plays a critical role in the synthesis of neurotransmitter precursors derived from tyrosine and tryptophan, including dopamine and serotonin.
By restoring metabolic balance and improving enzymatic function, Sepiapterin provides a targeted therapeutic option for patients with disorders of phenylalanine metabolism. It is intended for long-term management and may be used alongside dietary control and other supportive treatments to achieve optimal metabolic outcomes.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing